Cyclophosphamide hypersensitivity in a leukemic child

Therapeutic Drug Monitoring

Volumn 27, Issue 3, 2005, Pages 263-264

  Rosas Vargas, Miguel A ^a   Casas Becerra, Begonia ^a   Velázquez Armenta, Yadira ^a   Sienra Monge, Juan J L ^a   Del Río Navarro, Blanca E ^a  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Cutaneous tests; Cyclophosphamide; Desensitization

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANXIETY DISORDER; ARTICLE; CANCER RECURRENCE; CASE REPORT; DESENSITIZATION; DRUG HYPERSENSITIVITY; EDEMA; HUMAN; MALE; MEXICO; PRIORITY JOURNAL; PRURITUS; RASH; RESPIRATORY DISTRESS; SYMPTOMATOLOGY; TESTIS;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; DRUG HYPERSENSITIVITY; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE;

EID: 20044388728     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000161930.34775.45     Document Type: Article

References (11)

1. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
2. Olsson S. The role of the WHO program on International Drug Monitoring in coordinating worldwide drug safety efforts. Drug Saf. 1998;19:1-10.
3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200-1205.
4. Pichler WJ. Drug allergy: relationship between immunogenicity and clinical symptoms. Allergy. 1999;4(Suppl 5):5-7.
5. Popescu NA, Sheehan MG, Kouides PA, et al. Allergic reactions to cyclophosphamide: delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients. J Allergy Clin Immunol. 1996;97:26-33.
6. Minami R, Hirase N, Motomura S, et al. Anaphylactoid reaction to cyclophosphamide in a patient with T cell lymphoma and hemophagocytic syndrome. Int J Hematol. 1999;69:57-58.
7. Salles G, Vial T, Archimbaud E. Anaphylactoid reaction with bronchospasm following intravenous cyclophosphamide administration. Ann Hematol. 1991;62:74-75.
8. Karchmer RK, Hansen VL. Possible anaphylactic reaction to intravenous cyclophosphamide. Report of a case. JAMA. 1977;237:475.
9. Lakin JD, Cahill RA. Generalized urticaria to cyclophosphamide: Type 1 hypersensitivity to an immunosuppressive agent. J Allergy Clin Immunol. 1976;58:160-171.
10. Brockow K, Romano A, Blanca M, et al. General considerations for the skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57:45-51.
11. Borch RF, Millard JA. The mechanism of activation of 4- hydroxycyclophosphamide. J Med Chem. 1987;30:427-431.